Untitled Document

The role of PREVI in the Consortium is both to offer the technical expertise required for the development of the Anxiety Disorders module and to define the project exploitation plan toghether with VRHealth. In particular PREVI:

- will exploit the developed modules;
- will analyze and quantify the markets for virtual reality products and services,
- will profile the main companies, government organizations and academic groups currently developing virtual reality products.
- will also try to forecasts the pattern of new product development in the virtual reality/telepresence area and the likely future structure of the virtual reality/telepresence market.

PREVI is a SME enterprise. Its exclusive activity is centered in the development and marketing of VR solutions for the treatment of psychological disorders (PD). It is integrated in the European Centre of Innovation Business (CEEI-network).

At this moment the company is marketing three solutions. One for claustrophobia, one for body image problems in eating disorders and one for the treatment of anxiety disorders during the use of CT and MRI systems, these solutions are actually running in several spanish hospitals for their clinical validation.

PREVI has obtained several R&D projects funded from Spanish government for VR software developments in PD and it is currently co-funding several development
rojects aimed to the development of technical solutions in order to obtain useful